Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases

Infectious complications after 2-chlorodeoxyadenosine therapy

(2010) E. Neste et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland

(2010) T. Robak et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia

(2010) A. Hellmann et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Signals that maintain leukemic cell viability

(2008) J. Plate   BLOOD

A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma

(2008) Pier Luigi Zinzani et al.   CANCER

Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low‐grade B‐cell non‐Hodgkin lymphoma patients

(2008) Ewa Kalinka‐Warzocha et al.   CANCER

Transporter-Mediated Protection against Thiopurine-Induced Hematopoietic Toxicity

(2008) P. Krishnamurthy et al.   CANCER RESEARCH

The Combination of Clofarabine and Cytarabine in Pediatric Relapsed Acute Lymphoblastic Leukemia: A Case Report

(2008) Pooja Gidwani et al.   CHEMOTHERAPY

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

(2008) Tadeusz Robak   CURRENT CANCER DRUG TARGETS

Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides

(2008) C. de Wolf et al.   MOLECULAR CANCER THERAPEUTICS

FDA Drug Approval Summary: Nelarabine (Arranon(R)) for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma

(2008) M. H. Cohen et al.   ONCOLOGIST

Novel Purine Nucleoside Analogues for Hematological Malignancies

(2008) Anna Korycka et al.   Recent Patents on Anti-Cancer Drug Discovery